vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and Howard Hughes Holdings Inc. (HHH). Click either name above to swap in a different company.
Howard Hughes Holdings Inc. is the larger business by last-quarter revenue ($235.9M vs $185.2M, roughly 1.3× AMICUS THERAPEUTICS, INC.). Howard Hughes Holdings Inc. runs the higher net margin — 3.4% vs 0.9%, a 2.5% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 18.4%). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs -13.8%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Howard Hughes Holdings Inc., formerly the Howard Hughes Corporation, is a real estate development and management company based in The Woodlands, Texas. It was formed in 2010 as a spin-off from General Growth Properties (GGP). Most of its holdings are focused on several master-planned communities. It took its name from the original Howard Hughes Corporation, which had developed the planned community of Summerlin, Nevada, and later became a subsidiary of GGP.
FOLD vs HHH — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $185.2M | $235.9M |
| Net Profit | $1.7M | $8.1M |
| Gross Margin | 85.7% | — |
| Operating Margin | 8.6% | 121.6% |
| Net Margin | 0.9% | 3.4% |
| Revenue YoY | 23.7% | 18.4% |
| Net Profit YoY | -88.5% | -25.6% |
| EPS (diluted) | $0.00 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $235.9M | ||
| Q4 25 | $185.2M | $624.4M | ||
| Q3 25 | $169.1M | $390.2M | ||
| Q2 25 | $154.7M | $260.9M | ||
| Q1 25 | $125.2M | $199.3M | ||
| Q4 24 | $149.7M | $935.0M | ||
| Q3 24 | $141.5M | $327.1M | ||
| Q2 24 | $126.7M | $317.4M |
| Q1 26 | — | $8.1M | ||
| Q4 25 | $1.7M | $6.0M | ||
| Q3 25 | $17.3M | $119.5M | ||
| Q2 25 | $-24.4M | $-12.1M | ||
| Q1 25 | $-21.7M | $10.5M | ||
| Q4 24 | $14.7M | $156.3M | ||
| Q3 24 | $-6.7M | $72.8M | ||
| Q2 24 | $-15.7M | $21.1M |
| Q1 26 | — | — | ||
| Q4 25 | 85.7% | — | ||
| Q3 25 | 88.5% | — | ||
| Q2 25 | 90.2% | — | ||
| Q1 25 | 90.7% | — | ||
| Q4 24 | 90.1% | — | ||
| Q3 24 | 90.6% | — | ||
| Q2 24 | 91.1% | — |
| Q1 26 | — | 121.6% | ||
| Q4 25 | 8.6% | 4.2% | ||
| Q3 25 | 20.3% | 48.6% | ||
| Q2 25 | -6.1% | 26.0% | ||
| Q1 25 | -6.3% | 24.0% | ||
| Q4 24 | 10.7% | 33.5% | ||
| Q3 24 | 15.3% | 60.6% | ||
| Q2 24 | 11.8% | 20.4% |
| Q1 26 | — | 3.4% | ||
| Q4 25 | 0.9% | 1.0% | ||
| Q3 25 | 10.2% | 30.6% | ||
| Q2 25 | -15.8% | -4.7% | ||
| Q1 25 | -17.3% | 5.3% | ||
| Q4 24 | 9.8% | 16.7% | ||
| Q3 24 | -4.8% | 22.2% | ||
| Q2 24 | -12.4% | 6.6% |
| Q1 26 | — | $0.14 | ||
| Q4 25 | $0.00 | $0.20 | ||
| Q3 25 | $0.06 | $2.02 | ||
| Q2 25 | $-0.08 | $-0.22 | ||
| Q1 25 | $-0.07 | $0.21 | ||
| Q4 24 | $0.05 | $3.14 | ||
| Q3 24 | $-0.02 | $1.46 | ||
| Q2 24 | $-0.05 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $1.8B |
| Total DebtLower is stronger | $392.7M | — |
| Stockholders' EquityBook value | $274.2M | $3.8B |
| Total Assets | $949.9M | $11.2B |
| Debt / EquityLower = less leverage | 1.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.8B | ||
| Q4 25 | $293.5M | $1.5B | ||
| Q3 25 | $263.8M | $1.5B | ||
| Q2 25 | $231.0M | $1.4B | ||
| Q1 25 | $250.6M | $493.7M | ||
| Q4 24 | $249.9M | $596.1M | ||
| Q3 24 | $249.8M | $400.7M | ||
| Q2 24 | $260.1M | $436.8M |
| Q1 26 | — | — | ||
| Q4 25 | $392.7M | $5.1B | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | $5.1B | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — |
| Q1 26 | — | $3.8B | ||
| Q4 25 | $274.2M | $3.8B | ||
| Q3 25 | $230.4M | $3.8B | ||
| Q2 25 | $204.3M | $3.6B | ||
| Q1 25 | $193.6M | $2.8B | ||
| Q4 24 | $194.0M | $2.8B | ||
| Q3 24 | $178.8M | $2.6B | ||
| Q2 24 | $132.5M | $3.0B |
| Q1 26 | — | $11.2B | ||
| Q4 25 | $949.9M | $10.6B | ||
| Q3 25 | $868.8M | $10.7B | ||
| Q2 25 | $815.3M | $10.3B | ||
| Q1 25 | $789.8M | $9.3B | ||
| Q4 24 | $785.0M | $9.2B | ||
| Q3 24 | $786.6M | $9.4B | ||
| Q2 24 | $749.5M | $9.9B |
| Q1 26 | — | — | ||
| Q4 25 | 1.43× | 1.35× | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | 1.85× | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | — |
| Free Cash FlowOCF − Capex | $16.0M | — |
| FCF MarginFCF / Revenue | 8.6% | — |
| Capex IntensityCapex / Revenue | 0.2% | — |
| Cash ConversionOCF / Net Profit | 9.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $16.3M | $360.3M | ||
| Q3 25 | $35.7M | $149.8M | ||
| Q2 25 | $-26.5M | $177.3M | ||
| Q1 25 | $7.8M | $-224.9M | ||
| Q4 24 | $-3.9M | $337.1M | ||
| Q3 24 | $-23.0M | $248.3M | ||
| Q2 24 | $22.7M | $-17.5M |
| Q1 26 | — | — | ||
| Q4 25 | $16.0M | $348.6M | ||
| Q3 25 | $35.3M | $137.7M | ||
| Q2 25 | $-28.9M | $169.7M | ||
| Q1 25 | $7.5M | $-238.4M | ||
| Q4 24 | $-4.2M | $317.1M | ||
| Q3 24 | $-23.3M | $238.7M | ||
| Q2 24 | $21.6M | $-25.1M |
| Q1 26 | — | — | ||
| Q4 25 | 8.6% | 55.8% | ||
| Q3 25 | 20.9% | 35.3% | ||
| Q2 25 | -18.7% | 65.1% | ||
| Q1 25 | 6.0% | -119.6% | ||
| Q4 24 | -2.8% | 33.9% | ||
| Q3 24 | -16.5% | 73.0% | ||
| Q2 24 | 17.0% | -7.9% |
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | 1.9% | ||
| Q3 25 | 0.2% | 3.1% | ||
| Q2 25 | 1.6% | 2.9% | ||
| Q1 25 | 0.2% | 6.8% | ||
| Q4 24 | 0.2% | 2.1% | ||
| Q3 24 | 0.3% | 2.9% | ||
| Q2 24 | 0.9% | 2.4% |
| Q1 26 | — | — | ||
| Q4 25 | 9.62× | 60.04× | ||
| Q3 25 | 2.06× | 1.25× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -21.35× | ||
| Q4 24 | -0.27× | 2.16× | ||
| Q3 24 | — | 3.41× | ||
| Q2 24 | — | -0.83× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
HHH
| Rental revenue | $113.5M | 48% |
| Master Planned Communities land sales | $99.6M | 42% |
| Other revenues | $11.0M | 5% |
| Builder price participation | $8.7M | 4% |
| Condominium rights and unit sales | $3.1M | 1% |